DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr.Reddy's laboratories Limited
02 1APICORE PHARMACEUTICALS PRIVATE LIMITED
03 1CARBOGEN AMCIS AG
04 1Hetero Labs Limited
05 1MSN Laboratories Private Limited
06 1Mylan Laboratories Limited
07 1NATCO PHARMA LIMITED
08 2Olon SpA
09 1Viyash Life Sciences Private Limited
01 2POMALIDOMIDE
02 1POMALIDOMIDE MICRONIZED
03 7Pomalidomide
01 6India
02 2Italy
03 1Switzerland
04 1U.S.A
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-989
Start Marketing Date : 2017-04-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42973-232
Start Marketing Date : 2016-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 58567-109
Start Marketing Date : 2024-02-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68554-0091
Start Marketing Date : 2013-02-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0038
Start Marketing Date : 2015-10-06
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 70225-1106
Start Marketing Date : 2017-12-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (0.1kg/.1kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0068
Start Marketing Date : 2016-05-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0069
Start Marketing Date : 2016-05-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65015-893
Start Marketing Date : 2019-07-15
End Marketing Date : 2026-12-01
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 82245-0108
Start Marketing Date : 2013-02-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Pomalyst manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pomalyst, including repackagers and relabelers. The FDA regulates Pomalyst manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pomalyst API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pomalyst manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pomalyst supplier is an individual or a company that provides Pomalyst active pharmaceutical ingredient (API) or Pomalyst finished formulations upon request. The Pomalyst suppliers may include Pomalyst API manufacturers, exporters, distributors and traders.
click here to find a list of Pomalyst suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Pomalyst as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Pomalyst API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Pomalyst as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Pomalyst and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Pomalyst NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Pomalyst suppliers with NDC on PharmaCompass.
We have 9 companies offering Pomalyst
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
